The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
Dr. Prithviraj Bose explains how medical doctors tailor myelofibrosis remedies and the way sufferers can work with their care groups to navigate choices.The...
The FDA has granted quick monitor designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinomaThe U.S....
Anemia and gastrointestinal bleeding are among the many most typical signs for sufferers with gastrointestinal stromal tumors (GIST), defined Dr. Rosario Ligresti, chief...
